{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-101434","form_type":"8-K","ticker":"ADIL","cik":"0001513525","company_name":"ADIAL PHARMACEUTICALS, INC.","filed_at":"2026-09-18T20:27:15+00:00","discovered_at":"2026-09-18T20:28:04.617152+00:00","generated_at":"2026-09-18T20:28:14.691214+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Adial shareholders approve 5x authorized-share increase to 500M and new 2026 equity plans","bullets":["Authorized common shares increased from 100M to 500M (1,239,968 votes for, 37,210 against).","2026 Equity Incentive Plan approved: 3,078,147 new shares plus 196,670 returning shares and 5% annual evergreen through Jan 1, 2036.","Series F warrant exercise issuance of up to 552,940 shares approved under Nasdaq Listing Rule 5635(d).","2017 Plan share pool raised from 200,000 to 225,666 shares; ESPP approved; CBIZ CPAs ratified as auditor.","Meeting partially adjourned on 4 proposals pending Nasdaq conditional approval; reconvenes Oct 1, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-101434","json":"https://secwatch.observer/filing/0001213900-26-101434.json","markdown":"https://secwatch.observer/filing/0001213900-26-101434.md","text":"https://secwatch.observer/filing/0001213900-26-101434.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1513525/000121390026101434/0001213900-26-101434-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1513525/000121390026101434/ea0305933-8k_adial.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-18T20:28:14.691214+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}